FindMyRecallSubscribe
Class III: unlikely to cause harmOngoing

West-Ward Columbus Methotrexate Tablets Recall

Methotrexate Tablets, USP, 2

West-Ward Columbus Inc · Columbus, OH

Risk level
Class III
Reported by FDA
Nov 1, 2023
Recall ID
D-0066-2024
Check your lot numberHow we source this data

Summary

West-Ward Columbus recalled Methotrexate Tablets starting Sep 22, 2023. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0066-2024 on Nov 1, 2023. Reason: Failed Tablet/Capsule Specifications: Tablets were observed to have an unsmooth surface with two tablets demonstrating illegible tablet identification and scoring. Status: Ongoing.

Why it was recalled

Failed Tablet/Capsule Specifications: Tablets were observed to have an unsmooth surface with two tablets demonstrating illegible tablet identification and scoring.

Product description

Methotrexate Tablets, USP, 2.5 mg, 10x10 Unit-Dose Tablets per carton, Rx only, Distributed by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724. NDC: 0054-8550-25

Lot numbers, UPCs & expiration codes

Lot, expiry: Lot AB7486B, exp Dec 2023; Lot AB8766B, exp April 2024; Lot AB9484B, exp Aug 2024

Where it was sold

MS, OH

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0066-2024
Classification
Class III
Status
Ongoing
Recall initiated
Sep 22, 2023
FDA report date
Nov 1, 2023
Quantity
2,673 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
West-Ward Columbus Inc

Original FDA data

Every field from FDA enforcement report D-0066-2024, exactly as published.

Show all FDA fields
City
Columbus
State
OH
Status
Ongoing
Country
United States
Event ID
93223
Address
1809 Wilson Rd
Code information
Lot, expiry: Lot AB7486B, exp Dec 2023; Lot AB8766B, exp April 2024; Lot AB9484B, exp Aug 2024
Postal code
43228-9579
Report date
Nov 1, 2023
Product type
Drugs
Recall number
D-0066-2024
Classification
Class III
Recalling firm
West-Ward Columbus Inc
Product quantity
2,673 cartons
Reason for recall
Failed Tablet/Capsule Specifications: Tablets were observed to have an unsmooth surface with two tablets demonstrating illegible tablet identification and scoring.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Methotrexate Tablets, USP, 2.5 mg, 10x10 Unit-Dose Tablets per carton, Rx only, Distributed by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724. NDC: 0054-8550-25
Distribution pattern
MS, OH
Recall initiation date
Sep 22, 2023
Initial firm notification
Letter
Center classification date
Oct 23, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0066-2024, published Nov 1, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls